Expression of galectin-3 in primary and metastatic melanoma: Immunohistochemical studies on human lesions and nude mice xenograft tumors

Archives of Dermatological Research

Volumn 296, Issue 8, 2005, Pages 353-358

  Vereecken, Pierre ^a,b,f   Debray, Charles ^c   Petein, Michel ^d   Awada, Ahmad ^b   Lalmand, Marie Claude ^d   Laporte, Marianne ^a   Van Den Heule, Bernard ^e   Verhest, Alain ^b   Pochet, Roland ^c   Heenen, Michel ^a  

^a ERASME HOSPITAL   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

^d INSTITUTE OF PATHOLOGY AND GENETICS   (Belgium)

^e Ctr de Morphologie et de Pathologie   (Belgium)

^f NONE   (Belgium)

Author keywords

Galactose binding protein; Galectin 3; Melanoma

Indexed keywords

ANTIBODY; GALECTIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SKIN DEFECT; SKIN PIGMENTATION; STAINING; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEVUS; TRANSPLANTATION, HETEROLOGOUS;

EID: 20044362387     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-004-0536-6     Document Type: Article

References (33)

1. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hugues C, Kasai K (1994) Galectins: a family of animal beta-galactoside-binding lectins. Cell 76:597-598
2. Loris R (2002) Principles of structures of animal and plant lectins. Biochim Biophys Acta 1572:198-208
3. Yang RY, Liu FT (2003) Galectins in cell growth and apoptosis. Cell Mol Life Sci 60(2):267-276
4. Barondes SH (1997) Galectins: a personal overview. Trends Glycosci Glycotechnol 9(45): 1-7
5. Barondes SH, Cooper DNW, Gitt MA, Leffler H (1994) Galectins: structure and function of a large family of animal lectins. J Biol Chem 269(33):20807-20810
6. Hughes RC (1999) Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1473:172-185
7. Hughes RC (2001) Galectins as modulators of cell adhesion. Biochimie 83:667-676
8. Ochieng J, Green B, Evans S, James O, Warfield P (1998) Modulation of the biological functions of galectin-3 by matrix metalloproteinases. Biochim Biophys Acta 1379:97-106
9. Perillo NL, Marcus ME, Baum LG (1998) Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 76:402-412
10. Liu FT, Patterson RJ, Wang JL (2002) Intracellular functions of galectins. Biochim Biophys Acta 1572:263-273
11. Akahani S, Inohara H, Nangia-Makker P, Raz A (1997) Galectin-3 in tumor metastasis. Trends Glycosci Glycotechnol 9(45):69-75
12. Danguy A, Camby I, Kiss R (2002) Galectins and cancer. Biochim Biophys Acta 1572:285-293
13. Xu XC, El-Naggar AK, Lotan R (1995) Differential expression of galectin-1 and galectin-3 in thyroid tumors: potential diagnostic implications. Am J Pathol 147:815-822
14. Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia Makker P, Raz A (1998) Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin-3. Gastroenterology 115:287-296
15. Lotz MM, Andrews CW Jr, Korzelius CA, Lee EC, Steele GD Jr, Clarke A, Mercurio AM (1993) Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci U S A 90:3466-3470
16. Schoeppner HL, Raz A, Ho SB, Bresalier RS (1995) Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer 75:2818-2826
17. Inohara H, Raz A (1994) Effects of natural complex carbohydrate (citrus pectin) on melanoma cell properties related to galectin-3 functions. Glycoconj J 11(6):527-532
18. Seidal T, Balaton AJ, Battifora H (2001) Interpretation and quantification of immunostains. Am J Surg Pathol 25(9):1204-1207
19. Wick MR, Mills SE (2001) Consensual interpretive guidelines for diagnostic immunochemistry. Am J Surg Pathol 25(9):1208-1210
20. Price JE (2001) Xenograft models in immunodeficient animals. In: Brooks SA, Schumacher U (eds) Metastasis research protocols, vol II, Analysis of cell behaviour in vitro and in vivo. Humana Press, Totowa, pp 205-213
21. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli M, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF (2001) Final version of the American-Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol 19(16):3622-3634
22. Breslow A (1989) Prognosis in cutaneous melanoma: tumor thickness as a guide to treatment. Pathol Annu 24:383-407
23. Mey A, Berthier-Vergnes O, Apoil PA, Doré JF, Revillard JP (1994) Expression of the galactose binding protein Mac-2 by human melanoma cell lines. Cancer Lett 81:155-163
24. Santa Lucia P, Wilson BD, Allen HJ (1991) Localization of endogenous beta-galactoside-binding lectin as means to distinguish malignant from benign skin tissue. J Dermatol Surg Oncol 17(8):653-655
25. Kageshita T, Kashio Y, Yamauchi A, Seki M, Abedin MJ, Nishi N, Shoji H, Nakamura T, Ono T, Hirashima M (2002) Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer 99(6):806-816
26. Legendre H, Decaestecker C, Nagy N, Hendlisz A, Schüring MP, Salmon I, Gabius HJ, Pector JC, Kiss R (2003) Prognostic values of galectin-3 and the macrophage inhibitory factor (MIF) in human colorectal cancers. Mod Pathol 16(5):491-504
27. Castronovo V, Van Den Brûle FA, Jackers P, Clausse N, Liu FT, Gillet C, Sobel ME (1996) Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol 179:43-48
28. Matarrese P, Fusco O, Tinari N, Natoli C, Liu FT, Semeraro ML, Malorni W, Iacobelli S (2000) Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer 85(4):545-554
29. Woo HJ, Shaw LM, Messier JM, Mercurio AM (1990) The major non-integrin laminin binding protein of macrophages is identical to carbohydrate binding protein 35 (Mac-2). J Biol Chem 265:7097-7099
30. Johnson JP (1999) Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev 18:345-357
31. Warfield PR, Makker PN, Raz A, Ochieng J (1997) Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3. Invas Metast 17:101-112
32. Debray C, Vereecken P, Belot N, Teillard P, Brion JP, Pandolfo M, Pochet R (2004) Multifaceted role of galectin-3 on human glioblastoma cell motility. Biochem Biophys Res Commun 325:1393-1398
33. Ochieng J, Leite-Browning ML, Warfield P (1998) Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. Biochem Biophys Res Commun 246:788-791